U.S. Markets close in 4 hrs 54 mins

ICON Public Limited Company (ICLR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
104.76+2.32 (+2.26%)
As of 11:06AM EDT. Market open.
People also watch
PRXLCRLICUIIDXXIART

ICON Public Limited Company

South County Business Park
Leopardstown
Dublin 18
Ireland
353 1 291 2000
http://www.iconplc.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees12,327

Key Executives

NameTitlePayExercisedAge
Mr. Ciaran MurrayExec. Chairman2.13MN/A54
Mr. Brendan BrennanChief Financial Officer798kN/A38
Dr. Steven A. Cutler Ph.D., MBAChief Exec. Officer and DirectorN/AN/A57
Mr. Thomas O'LearyChief Information OfficerN/AN/AN/A
Mr. Diarmaid CunninghamChief Admin. Officer, Gen. Counsel, Exec. VP and Company Sec.N/AN/A42
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. Its clinical development services comprise product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, clinical research center, investigator site, patient recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety and risk-based monitoring, clinical data management, strategic analysis and data operation, regulatory consulting, and medical reporting and pharmacovigilance services. The company’s clinical development services also comprise interactive response technologies, electronic endpoint adjudication, medical imaging, adaptive trial design and execution, medical device and biosimilar trial, functional, strategic resourcing, sample analyses, safety testing, microbiology, custom flow cytometry, biomarker development, bioanalysis, immunoassay development, patient registries, outcomes research, health economics, market access and commercialization, drug price consulting, and healthcare and scientific communication services, as well as research trials for US government agencies, electronic transmission of test results, and electronic patient reported outcomes. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.

Corporate Governance

ICON Public Limited Company’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.